| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b2e1b066143d32eead4b224768350c50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a6e8dd057c094c988411bdef18feeab7 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate |
2003-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dab9839e0e11b140c447a8d68021a1ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1de2dae51dac603c5eda1238597dcb4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0b60c6af258962523d8047eb53081b9 |
| publicationDate |
2005-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1567125-A2 |
| titleOfInvention |
Pharmaceutical compositions suitable for the treatment of ophthalmic diseases |
| abstract |
Pharmaceutical compositions for the treatment of ophthalmic diseases, suitable for topical ocular administration and for systemic administration, comprising solid lipid nanoparticles (SLNs) with a mean diameter comprised between 50 and 400 nm wherein, within said nanoparticles, a pharmacologically active substance for the specific ophthalmic treatment is incorporated. |
| priorityDate |
2002-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |